Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jayashree Kalpathy-Cramer

Concepts (405)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
37
2026
181
6.460
 Why?
Artificial Intelligence
39
2025
381
5.150
 Why?
Image Processing, Computer-Assisted
24
2026
782
4.400
 Why?
Glioblastoma
16
2024
354
3.140
 Why?
Brain Neoplasms
24
2024
1331
3.060
 Why?
Machine Learning
23
2026
587
2.780
 Why?
Algorithms
41
2026
1850
2.710
 Why?
Uterine Cervical Neoplasms
8
2025
268
2.340
 Why?
Diagnostic Imaging
19
2024
337
2.120
 Why?
Radiology
10
2024
174
1.860
 Why?
Natural Language Processing
7
2023
106
1.810
 Why?
Magnetic Resonance Imaging
41
2024
3915
1.740
 Why?
Geographic Atrophy
2
2026
97
1.680
 Why?
Information Storage and Retrieval
8
2015
123
1.640
 Why?
Retina
7
2026
329
1.500
 Why?
Neuroimaging
7
2022
300
1.460
 Why?
Glioma
8
2022
429
1.370
 Why?
Image Interpretation, Computer-Assisted
14
2026
288
1.360
 Why?
Cervix Uteri
3
2025
50
1.320
 Why?
Radiotherapy Planning, Computer-Assisted
5
2016
149
1.230
 Why?
ROC Curve
17
2026
618
1.080
 Why?
Papillomavirus Infections
5
2025
344
1.070
 Why?
Software
10
2024
680
1.030
 Why?
Humans
165
2026
145750
1.010
 Why?
Colposcopy
2
2025
18
0.980
 Why?
Optic Disk
2
2025
53
0.950
 Why?
Telemedicine
8
2026
963
0.930
 Why?
Optical Imaging
1
2026
62
0.900
 Why?
Severity of Illness Index
10
2026
2933
0.870
 Why?
Glaucoma
2
2025
251
0.870
 Why?
Gestational Age
19
2026
989
0.860
 Why?
Tomography, X-Ray Computed
15
2023
2770
0.850
 Why?
Fundus Oculi
6
2026
89
0.850
 Why?
Infant, Newborn
37
2026
6464
0.840
 Why?
Retinal Vessels
7
2026
77
0.820
 Why?
Tomography, Optical Coherence
2
2025
271
0.800
 Why?
Reproducibility of Results
28
2025
3416
0.790
 Why?
Solitary Pulmonary Nodule
3
2021
25
0.760
 Why?
Radiology Information Systems
4
2022
35
0.760
 Why?
Privacy
1
2023
41
0.750
 Why?
Ophthalmology
5
2023
120
0.740
 Why?
Diagnostic Techniques, Ophthalmological
3
2018
53
0.730
 Why?
Breast Neoplasms
7
2024
2393
0.720
 Why?
Ophthalmoscopy
8
2024
38
0.690
 Why?
Radiologists
4
2024
61
0.670
 Why?
Bronchopulmonary Dysplasia
1
2026
420
0.640
 Why?
Neonatal Screening
6
2026
179
0.640
 Why?
Sensitivity and Specificity
14
2024
2000
0.640
 Why?
Crowdsourcing
1
2020
18
0.630
 Why?
Medicine
1
2021
125
0.610
 Why?
Breast Density
3
2024
8
0.590
 Why?
Mammography
4
2024
166
0.570
 Why?
Stroke
3
2023
1271
0.540
 Why?
Retinal Vein
4
2021
14
0.530
 Why?
Retrospective Studies
27
2026
17322
0.530
 Why?
Isocitrate Dehydrogenase
1
2017
72
0.510
 Why?
Infant, Premature
12
2026
620
0.510
 Why?
Female
60
2026
79025
0.510
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
109
0.480
 Why?
Lung Neoplasms
5
2021
2667
0.470
 Why?
Tumor Burden
4
2023
325
0.470
 Why?
Phenylurea Compounds
1
2016
119
0.460
 Why?
Databases, Factual
8
2021
1491
0.450
 Why?
Chemoradiotherapy
7
2023
239
0.450
 Why?
Gallbladder Neoplasms
3
2011
20
0.450
 Why?
Quinolines
1
2016
190
0.450
 Why?
Prostatic Neoplasms
5
2024
981
0.440
 Why?
Peripheral Arterial Disease
4
2023
507
0.440
 Why?
Radiography, Thoracic
5
2022
172
0.440
 Why?
Pattern Recognition, Automated
5
2023
74
0.430
 Why?
Benchmarking
6
2024
191
0.430
 Why?
Uterine Cervical Dysplasia
2
2025
27
0.430
 Why?
Delivery of Health Care
1
2021
947
0.420
 Why?
Hypertension, Pulmonary
1
2026
1957
0.420
 Why?
Subtraction Technique
1
2014
26
0.410
 Why?
Male
54
2026
72992
0.410
 Why?
Radiation Oncology
2
2014
82
0.410
 Why?
Retinal Artery
3
2021
17
0.410
 Why?
Vocabulary, Controlled
1
2014
47
0.400
 Why?
Photography
6
2021
119
0.400
 Why?
Neoplasm Recurrence, Local
2
2019
1150
0.400
 Why?
Early Detection of Cancer
5
2025
486
0.400
 Why?
White Matter
3
2023
155
0.390
 Why?
Phantoms, Imaging
7
2023
159
0.390
 Why?
Multimodal Imaging
1
2014
129
0.380
 Why?
Datasets as Topic
5
2021
118
0.370
 Why?
Survival Analysis
4
2016
1378
0.350
 Why?
Middle Aged
32
2025
36297
0.350
 Why?
Aged
30
2025
26212
0.350
 Why?
Cerebral Blood Volume
3
2020
5
0.340
 Why?
Radiotherapy, Conformal
1
2011
74
0.340
 Why?
Contrast Media
9
2020
497
0.340
 Why?
Internet
2
2014
693
0.330
 Why?
Mass Screening
4
2025
1361
0.330
 Why?
Adrenoleukodystrophy
2
2023
9
0.330
 Why?
Clinical Competence
2
2016
1247
0.320
 Why?
Proportional Hazards Models
4
2011
1330
0.310
 Why?
Brain
8
2021
2969
0.310
 Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
122
0.310
 Why?
Precision Medicine
3
2024
461
0.300
 Why?
Medical Informatics
4
2020
100
0.300
 Why?
Head and Neck Neoplasms
5
2020
561
0.300
 Why?
Neoplasms
7
2024
2913
0.290
 Why?
Database Management Systems
1
2008
51
0.280
 Why?
User-Computer Interface
4
2015
165
0.270
 Why?
Radiotherapy, Adjuvant
1
2008
222
0.270
 Why?
Automation
5
2020
104
0.260
 Why?
Endovascular Procedures
2
2023
390
0.260
 Why?
Observer Variation
4
2024
357
0.260
 Why?
Lung
6
2022
4116
0.250
 Why?
Adult
27
2025
40867
0.250
 Why?
Prognosis
9
2024
4329
0.250
 Why?
Risk Factors
10
2026
10916
0.240
 Why?
Radiography
5
2022
853
0.230
 Why?
Diffusion Magnetic Resonance Imaging
2
2018
156
0.220
 Why?
Endoscopy, Gastrointestinal
1
2007
237
0.220
 Why?
Uncertainty
1
2026
146
0.220
 Why?
Oropharyngeal Neoplasms
2
2015
56
0.220
 Why?
Antineoplastic Agents
1
2016
2219
0.220
 Why?
Rectal Neoplasms
2
2021
159
0.220
 Why?
Predictive Value of Tests
5
2025
2123
0.220
 Why?
Reference Standards
7
2021
177
0.210
 Why?
Neoplasm Grading
3
2024
311
0.210
 Why?
Adenocarcinoma in Situ
1
2023
1
0.200
 Why?
Forecasting
3
2019
390
0.200
 Why?
Statistics as Topic
2
2014
283
0.190
 Why?
Ranibizumab
1
2023
21
0.190
 Why?
Postoperative Care
2
2019
286
0.190
 Why?
Imaging, Three-Dimensional
4
2023
583
0.190
 Why?
Neovascularization, Pathologic
3
2024
287
0.190
 Why?
Radiotherapy, Intensity-Modulated
4
2016
142
0.190
 Why?
Diagnosis, Computer-Assisted
2
2021
92
0.180
 Why?
Myeloid-Derived Suppressor Cells
1
2023
76
0.180
 Why?
Long QT Syndrome
1
2023
68
0.180
 Why?
Oxygen
2
2021
981
0.180
 Why?
Biomedical Research
3
2024
719
0.180
 Why?
Documentation
2
2015
199
0.180
 Why?
Macular Degeneration
1
2024
191
0.180
 Why?
Quality Assurance, Health Care
2
2014
342
0.180
 Why?
Computer Communication Networks
2
2020
32
0.180
 Why?
Diverticulitis
1
2021
8
0.170
 Why?
Rheumatic Diseases
1
2022
98
0.170
 Why?
Patient-Specific Modeling
2
2024
45
0.170
 Why?
Infant
11
2024
10089
0.170
 Why?
Biomarkers
4
2018
4302
0.170
 Why?
Hospital Units
1
2021
32
0.170
 Why?
Cohort Studies
6
2022
6032
0.170
 Why?
Racism
1
2023
147
0.160
 Why?
Musculoskeletal System
1
2021
54
0.160
 Why?
Intestinal Obstruction
1
2021
55
0.160
 Why?
India
1
2021
213
0.160
 Why?
Dacarbazine
3
2015
100
0.160
 Why?
Tibial Meniscus Injuries
1
2021
62
0.160
 Why?
Perfusion Imaging
1
2020
66
0.160
 Why?
Radiometry
1
2020
56
0.160
 Why?
Microcirculation
2
2017
142
0.160
 Why?
Hyperemia
1
2020
49
0.150
 Why?
Health Information Exchange
1
2020
23
0.150
 Why?
Medical Records Systems, Computerized
2
2013
95
0.150
 Why?
Carcinoma, Squamous Cell
2
2015
641
0.150
 Why?
Biomarkers, Tumor
3
2016
1329
0.150
 Why?
Brain Ischemia
1
2023
359
0.150
 Why?
Signal Processing, Computer-Assisted
2
2017
152
0.150
 Why?
Cerebellar Neoplasms
1
2022
177
0.150
 Why?
Area Under Curve
4
2021
332
0.150
 Why?
Brain Diseases
1
2021
155
0.150
 Why?
Low Back Pain
1
2021
108
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2023
552
0.150
 Why?
Medulloblastoma
1
2022
215
0.150
 Why?
Lung Injury
1
2022
249
0.150
 Why?
Appendicitis
1
2021
150
0.150
 Why?
Positron Emission Tomography Computed Tomography
1
2020
118
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2023
699
0.150
 Why?
Antineoplastic Agents, Alkylating
2
2018
74
0.150
 Why?
Aneurysm, Ruptured
1
2019
38
0.150
 Why?
Capillary Permeability
1
2019
132
0.140
 Why?
Age Determination by Skeleton
1
2018
16
0.140
 Why?
Models, Biological
4
2024
1764
0.140
 Why?
Treatment Outcome
8
2023
11793
0.140
 Why?
Risk Assessment
5
2026
3752
0.140
 Why?
Blood-Brain Barrier
2
2017
160
0.140
 Why?
Cone-Beam Computed Tomography
1
2018
32
0.140
 Why?
Linear Models
1
2021
849
0.140
 Why?
Drug Resistance, Neoplasm
1
2024
883
0.140
 Why?
Colonic Neoplasms
1
2021
258
0.140
 Why?
Intracranial Aneurysm
1
2019
106
0.140
 Why?
Arteries
2
2019
261
0.140
 Why?
Ventricular Dysfunction, Right
1
2021
248
0.130
 Why?
Antibodies, Monoclonal, Humanized
1
2024
992
0.130
 Why?
Medical Record Linkage
1
2018
69
0.130
 Why?
Global Health
1
2021
403
0.130
 Why?
Prospective Studies
7
2023
8075
0.130
 Why?
Gadolinium
1
2017
84
0.130
 Why?
Polysaccharides, Bacterial
1
2017
69
0.130
 Why?
Bayes Theorem
2
2016
421
0.130
 Why?
Respiratory Insufficiency
1
2021
326
0.130
 Why?
Diagnosis, Differential
3
2019
1512
0.130
 Why?
Preoperative Period
1
2017
149
0.130
 Why?
Gray Matter
1
2018
92
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1969
0.130
 Why?
Patient Readmission
1
2022
772
0.120
 Why?
North America
3
2024
303
0.120
 Why?
Computer Simulation
5
2024
1003
0.120
 Why?
Skin Diseases, Genetic
1
2016
13
0.120
 Why?
Blood Vessels
1
2017
167
0.120
 Why?
Chronic Pain
1
2021
291
0.120
 Why?
Pharyngeal Muscles
1
2016
5
0.120
 Why?
Nasopharyngeal Neoplasms
1
2016
21
0.120
 Why?
SEER Program
3
2011
230
0.120
 Why?
Angiogenesis Inhibitors
2
2016
239
0.110
 Why?
National Cancer Institute (U.S.)
3
2020
54
0.110
 Why?
Blood Volume Determination
1
2015
4
0.110
 Why?
Vascular Malformations
1
2016
52
0.110
 Why?
Liver Cirrhosis
1
2017
287
0.110
 Why?
Acute Kidney Injury
1
2023
875
0.110
 Why?
Fibrosis
1
2017
561
0.110
 Why?
Positron-Emission Tomography
4
2021
343
0.110
 Why?
Cranial Irradiation
1
2015
85
0.110
 Why?
Physical Phenomena
1
2014
13
0.110
 Why?
Organs at Risk
1
2014
37
0.110
 Why?
Radiation Injuries
1
2016
149
0.110
 Why?
Birth Weight
3
2023
517
0.110
 Why?
Societies, Medical
3
2024
900
0.110
 Why?
Brachial Plexus
1
2014
34
0.100
 Why?
Longitudinal Studies
2
2019
2967
0.100
 Why?
Aged, 80 and over
5
2018
8346
0.100
 Why?
Chemoradiotherapy, Adjuvant
2
2011
44
0.100
 Why?
Tumor Microenvironment
1
2018
735
0.100
 Why?
Deglutition Disorders
1
2016
154
0.100
 Why?
Joint Instability
1
2016
183
0.100
 Why?
Administration, Oral
1
2016
867
0.100
 Why?
Mutation
3
2024
4090
0.100
 Why?
Computer-Assisted Instruction
1
2014
70
0.100
 Why?
Bias
3
2024
197
0.100
 Why?
Arteriovenous Malformations
1
2013
33
0.100
 Why?
Computer Literacy
1
2013
5
0.100
 Why?
Health Information Systems
1
2013
16
0.090
 Why?
Young Adult
7
2018
14250
0.090
 Why?
Survival Rate
3
2018
2094
0.090
 Why?
Terminology as Topic
1
2014
259
0.090
 Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
 Why?
Nomograms
1
2011
59
0.080
 Why?
Research Design
2
2014
1139
0.080
 Why?
Workload
1
2013
169
0.080
 Why?
Feasibility Studies
2
2014
1115
0.080
 Why?
Child
8
2024
22738
0.080
 Why?
Support Vector Machine
2
2021
33
0.080
 Why?
Muscle, Skeletal
1
2020
1791
0.080
 Why?
Papillomaviridae
2
2023
116
0.070
 Why?
Periodicals as Topic
1
2012
209
0.070
 Why?
Liver
1
2017
1899
0.070
 Why?
Oregon
1
2008
77
0.070
 Why?
Emergency Service, Hospital
1
2021
2383
0.070
 Why?
Total Quality Management
1
2008
57
0.070
 Why?
Lower Extremity
2
2023
445
0.070
 Why?
United States
5
2024
16122
0.070
 Why?
Exercise
1
2020
2203
0.070
 Why?
MEDLINE
1
2008
20
0.070
 Why?
Dilatation, Pathologic
2
2018
61
0.070
 Why?
Breast
2
2019
156
0.070
 Why?
Follow-Up Studies
3
2024
5428
0.060
 Why?
Protein Kinase Inhibitors
1
2013
981
0.060
 Why?
Randomized Controlled Trials as Topic
2
2025
1751
0.060
 Why?
Monte Carlo Method
2
2017
148
0.060
 Why?
Electronic Health Records
1
2015
1202
0.060
 Why?
Cluster Analysis
1
2007
501
0.060
 Why?
Clinical Protocols
2
2019
280
0.060
 Why?
Tanzania
1
2025
72
0.060
 Why?
Vaginal Smears
1
2025
54
0.060
 Why?
Proof of Concept Study
1
2024
89
0.050
 Why?
Netherlands
1
2024
84
0.050
 Why?
Critical Illness
2
2021
900
0.050
 Why?
Kinetics
2
2019
1568
0.050
 Why?
Physicians
1
2013
956
0.050
 Why?
Intensive Care Units, Neonatal
2
2018
293
0.050
 Why?
Brain Infarction
1
2023
23
0.050
 Why?
Ethers, Cyclic
1
2023
11
0.050
 Why?
DNA, Viral
1
2025
356
0.050
 Why?
Troponin T
1
2023
63
0.050
 Why?
Benzofurans
1
2023
26
0.050
 Why?
Models, Theoretical
2
2021
560
0.050
 Why?
X-Rays
1
2022
27
0.050
 Why?
DNA Helicases
1
2024
136
0.050
 Why?
Data Curation
1
2022
21
0.050
 Why?
Adrenal Glands
1
2022
76
0.050
 Why?
Quinazolines
2
2013
266
0.040
 Why?
Smartphone
1
2023
107
0.040
 Why?
Logistic Models
2
2021
2139
0.040
 Why?
Health Services
1
2022
113
0.040
 Why?
Cross-Sectional Studies
2
2024
5921
0.040
 Why?
Limb Salvage
1
2022
73
0.040
 Why?
Antineoplastic Agents, Immunological
1
2024
198
0.040
 Why?
Vagina
1
2024
203
0.040
 Why?
Edema
1
2022
125
0.040
 Why?
Utilization Review
1
2021
39
0.040
 Why?
Receptors, GABA
1
2021
13
0.040
 Why?
Nepal
1
2021
32
0.040
 Why?
Genetic Therapy
1
2023
316
0.040
 Why?
Case-Control Studies
2
2019
3634
0.040
 Why?
Massachusetts
1
2021
180
0.040
 Why?
Early Diagnosis
1
2021
251
0.040
 Why?
Neoadjuvant Therapy
1
2024
467
0.040
 Why?
Genotype
1
2025
1857
0.040
 Why?
Clinical Trials as Topic
2
2016
1062
0.040
 Why?
Abdomen
1
2021
142
0.040
 Why?
Incidence
2
2020
2933
0.040
 Why?
Internationality
1
2021
156
0.040
 Why?
Cell Cycle Proteins
1
2024
630
0.040
 Why?
Ankle
1
2020
64
0.040
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
30
0.040
 Why?
Models, Statistical
2
2016
672
0.040
 Why?
Seizures
1
2024
485
0.040
 Why?
Indoles
2
2013
507
0.040
 Why?
Hematopoietic Stem Cells
1
2023
435
0.040
 Why?
Disease Progression
2
2020
2865
0.040
 Why?
Hand Bones
1
2018
3
0.040
 Why?
Risk
1
2021
923
0.040
 Why?
Infant, Low Birth Weight
1
2020
156
0.040
 Why?
Nuclear Proteins
1
2024
740
0.040
 Why?
Quality Control
1
2019
161
0.040
 Why?
Bevacizumab
1
2019
168
0.040
 Why?
Genomics
1
2024
831
0.040
 Why?
Arthroscopy
1
2021
268
0.040
 Why?
Reference Values
1
2020
798
0.030
 Why?
Hyperlipidemias
1
2019
120
0.030
 Why?
Radiation Exposure
1
2019
63
0.030
 Why?
Ventricular Function, Right
1
2021
297
0.030
 Why?
Medical Oncology
1
2021
340
0.030
 Why?
Hemizygote
1
2017
6
0.030
 Why?
Ecosystem
1
2022
478
0.030
 Why?
Carbon Tetrachloride
1
2017
13
0.030
 Why?
Half-Life
1
2017
155
0.030
 Why?
Diabetic Retinopathy
1
2020
209
0.030
 Why?
Diffusion
1
2017
120
0.030
 Why?
Permeability
1
2017
169
0.030
 Why?
Skull
1
2018
163
0.030
 Why?
Chemotherapy, Adjuvant
1
2018
427
0.030
 Why?
Asymptomatic Diseases
1
2017
104
0.030
 Why?
Tissue Distribution
1
2017
335
0.030
 Why?
Outpatients
1
2021
447
0.030
 Why?
Information Dissemination
1
2019
224
0.030
 Why?
Signal-To-Noise Ratio
1
2016
73
0.030
 Why?
Expert Systems
1
2016
4
0.030
 Why?
Prostate
1
2017
159
0.030
 Why?
Palate, Soft
1
2016
11
0.030
 Why?
Heart Ventricles
1
2021
756
0.030
 Why?
Respiration, Artificial
1
2021
714
0.030
 Why?
Dose-Response Relationship, Radiation
1
2016
141
0.030
 Why?
Evaluation Studies as Topic
1
2016
164
0.030
 Why?
Transcription Factors
1
2024
1736
0.030
 Why?
Antineoplastic Protocols
1
2015
6
0.030
 Why?
Magnetic Resonance Angiography
1
2017
251
0.030
 Why?
Molecular Imaging
1
2016
57
0.030
 Why?
Video Recording
1
2017
219
0.030
 Why?
Platelet Count
1
2015
94
0.030
 Why?
Radiotherapy Dosage
1
2016
288
0.030
 Why?
Motion
1
2015
95
0.030
 Why?
Perfusion
1
2016
251
0.030
 Why?
Diffusion Tensor Imaging
1
2015
78
0.030
 Why?
Cerebrovascular Circulation
1
2017
290
0.030
 Why?
Disease-Free Survival
1
2016
770
0.030
 Why?
Thoracic Neoplasms
1
2014
39
0.030
 Why?
Intensive Care Units
1
2021
924
0.030
 Why?
Mass Spectrometry
1
2017
731
0.030
 Why?
Comorbidity
1
2019
1662
0.030
 Why?
Image Enhancement
1
2015
200
0.030
 Why?
Carcinoma
1
2016
227
0.030
 Why?
DNA Modification Methylases
1
2013
18
0.030
 Why?
DNA Repair Enzymes
1
2013
29
0.020
 Why?
Congresses as Topic
1
2015
224
0.020
 Why?
Argentina
1
2013
30
0.020
 Why?
Child, Preschool
2
2018
11866
0.020
 Why?
Pandemics
1
2021
1711
0.020
 Why?
Statistics, Nonparametric
1
2013
428
0.020
 Why?
Molecular Targeted Therapy
1
2016
440
0.020
 Why?
Fluorescein Angiography
1
2013
190
0.020
 Why?
Adolescent
3
2018
22569
0.020
 Why?
Smoking
1
2019
1477
0.020
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.020
 Why?
Life Tables
1
2011
21
0.020
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2013
849
0.020
 Why?
Hemodynamics
1
2016
1118
0.020
 Why?
Tumor Suppressor Proteins
1
2013
322
0.020
 Why?
Time Factors
1
2022
7133
0.020
 Why?
Polymerase Chain Reaction
1
2013
1043
0.020
 Why?
Educational Status
1
2013
470
0.020
 Why?
Pregnancy
1
2023
7215
0.020
 Why?
Diabetes Mellitus
1
2019
1101
0.020
 Why?
Hypertension
1
2019
1276
0.020
 Why?
Probability
1
2011
308
0.020
 Why?
Hospitalization
1
2021
2460
0.020
 Why?
Lymphatic Metastasis
1
2011
336
0.020
 Why?
Pilot Projects
1
2015
1897
0.020
 Why?
Rats
1
2017
5585
0.020
 Why?
Kaplan-Meier Estimate
1
2011
971
0.020
 Why?
PubMed
1
2008
15
0.020
 Why?
Ultrasonography
1
2012
788
0.020
 Why?
Disease Models, Animal
1
2017
4569
0.020
 Why?
Neoplasm Staging
1
2011
1474
0.020
 Why?
Attitude of Health Personnel
1
2013
1196
0.010
 Why?
Age Factors
1
2011
3346
0.010
 Why?
Internship and Residency
1
2014
1269
0.010
 Why?
Mice
1
2017
18357
0.010
 Why?
Animals
1
2017
38100
0.010
 Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (405) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)